Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Wor
about
Aromatase inhibitors for short stature in male children and adolescentsAromatase inhibitors for short stature in male children and adolescentsControversies in the definition and treatment of idiopathic short stature (ISS)GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.Emerging options in growth hormone therapy: an updateChallenges in the Diagnosis and Management of Growth Hormone Deficiency in IndiaGrowth Hormone Research Society perspective on the development of long-acting growth hormone preparationsRisk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.Depression and self-concept in girls with perception of pubertal onsetGrowth hormone treatment in non-growth hormone-deficient childrenEtiological factors of short stature in children and adolescents: experience at a tertiary care hospital in Egypt.Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit.Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutationsContextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology.Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency: an analysis from a prospective observational study.Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.Whole exome sequencing to identify genetic causes of short statureA novel TRPS1 gene mutation causing trichorhinophalangeal syndrome with growth hormone responsive short stature: a case report and review of the literature.Genetic evaluation of short stature.Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.Factors influencing the one- and two-year growth response in children treated with growth hormone: analysis from an observational study.Estrogens and Androgens in Skeletal Physiology and Pathophysiology.Effects of growth hormone and nutritional therapy in boys with constitutional growth delay: a randomized controlled trial.Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty.The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®.Evaluation of the American-English Quality of Life in Short Stature Youth (QoLISSY) questionnaire in the United States.A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short statureIdentification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy.Idiopathic short stature due to novel heterozygous mutation of the aggrecan geneRecombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.Meier-Gorlin syndrome genotype-phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosisGenetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear GrowthAssociations between Psychological Problems and Quality of Life in Pediatric Short Stature from Patients' and Parents' PerspectivesClinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.A Leri-Weill dyschondrosteosis patient confirmed by mutation analysis of SHOX gene.Comparison of response to 2-years' growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large obseThe Impact and Successes of a Paediatric Endocrinology Fellowship Program in Africa
P2860
Q24186574-A6342D5E-A721-43D7-A24F-0B5642A0A53BQ24202097-5A955D12-FA97-474B-8F41-8F016DB3768EQ24626074-E7D32EBC-3B40-4812-92C1-5D475E9AEA36Q26777290-6FA67C02-1D77-4294-B964-70F005B83B7BQ27014666-F6F3CDE4-48A4-4E9D-BD84-81EABBCA3F44Q28076439-4FD78410-F41C-4C59-8973-8A0EC324AE50Q30277101-6E7DC133-AF55-4A32-A27C-9720C614C189Q33570283-CF069BAE-FD3F-49DB-9018-6211EF04B701Q33635259-CEF975FF-64D4-4F42-A6E7-57905F7BD556Q33726962-1AE57B46-E274-46BB-BCD5-ABB07E7F5BDEQ33788096-7EC110F3-BCA2-475B-8618-F61DBE6FF8AEQ33965052-77B813DD-E9BA-43BD-BB51-78146E289646Q33966042-8A2AF28B-C678-4B10-9EEC-0A1832EDF2EEQ33999000-135B67B5-CA5E-41E7-8A40-9B0F90ADB586Q34009361-BC2C8A8E-F030-4ED0-9FA5-25076D8B9BD9Q34017482-362DC469-1186-473A-97F3-64DDFE1BB9D1Q34017922-48E43F6D-59BA-46CB-98BA-EA0FB2E434F2Q34033624-3B754061-7DC4-49E1-8BEE-6E55D64C9F50Q34106514-1CC0FA6E-B308-461B-8D19-BB505CE1E82DQ34130975-2920E254-BDCA-42DE-8A1B-D34D2B17E1E8Q34159910-5DE0DB92-983B-4994-9DA7-C6011AF3B4B6Q34210830-92538410-F145-44C9-B763-A93E58AEBEC1Q34543980-81E81D45-A157-40EB-A74A-484E867A9C51Q34553943-BBF4581A-9255-46B7-AFA2-1B7B4C9F36D1Q35052389-5D876AE6-4238-4E72-BCD2-4A2755EC0FBEQ35186243-4C43A612-5297-47C6-8288-7700F7017CFCQ35200538-AE0EBE0D-A000-4929-B11C-3F62C5445FC8Q35583784-8C9367C1-0D11-4C7D-A445-41F8093AF870Q35601201-A642C59C-EF2B-48D8-BA1A-F78B52A9B240Q35603697-F1AC575E-414A-418E-AD32-0CBADFDFA613Q35749319-E8420F95-A79A-4BE8-AD5D-E5E51F3E0B9EQ35850399-5570F250-A26F-419A-8C52-062DF0841AEAQ35859413-53424B29-70F3-4273-A459-F0889E1909BDQ35969087-32D11072-0F42-4F0C-8B3C-B00AD239B9D5Q35972326-D9BD08A7-5C19-4EE1-9FFA-849435778BE8Q35994873-F581F75D-C146-45EB-9D88-540AF3C71C57Q36040109-0A8DCCF9-7438-4480-9BA9-37130304E30AQ36215774-A33B5297-7897-4DAC-B09E-D51ACBB831A9Q36232825-59B6AC5A-47AE-4456-8338-224A05A99456Q36556199-72CDCCAE-3C17-4746-9002-04A977CA41F0
P2860
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Wor
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@en
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@nl
type
label
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@en
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@nl
prefLabel
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@en
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@nl
P2093
P356
P1476
Consensus statement on the dia ...... r Paediatric Endocrinology Wor
@en
P2093
2007 ISS Consensus Workshop participants
E O Reiter
M O Savage
S D Chernausek
P304
P356
10.1210/JC.2008-0509
P407
P577
2008-09-09T00:00:00Z